James Hendrix

+1 781 825-1307
jhendrix@lumindrds.org

 

James Hendrix

Chief Scientific Officer

Prior to joining LuMind, Dr. Hendrix was director, global science initiatives, at the Alzheimer’s Association. As a member of the Medical and Scientific Relations Division, he provided leadership on specific domestic and international efforts focused on advancing the division’s science agenda. A critical element of his role is to manage industry consortia such as the Alzheimer’s Association Research Roundtable (AARR); lead the Global Biomarker Standardization Consortium; manage and direct future meeting efforts and output; and assist with the coordination of the $100 million dollar Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study on the clinical usefulness of amyloid PET imaging.

Before joining the Alzheimer’s Association, Dr. Hendrix was a pharmaceutical scientist with a focus on drug discovery for CNS diseases. Dr. Hendrix spent 18 years working at Sanofi-Aventis and predecessor companies, where he rose to level of senior director, U.S. site head for CNS research. He also spent two years working in the biotech industry with various companies, including companies focused on the treatment of Alzheimer’s disease.

Dr. Hendrix received his Ph.D. and a postdoctoral fellowship from Colorado State University.